MRE11:p.K464R mutation mediates olaparib resistance by enhancing DNA damage repair in HGSOC
Although the clinical application of PARP inhibitors has brought hope to ovarian cancer, the problem of its resistance has become increasingly prominent. Therefore, clinical experts have been focused on findin...